Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats

Anesthesia and Analgesia

Volumn 86, Issue 4, 1998, Pages 830-836

  McCarthy, Robert J ^a,b   Kroin, Jeffrey S ^a   Tuman, Kenneth J ^a   Penn, Richard D ^a   Ivankovich, Anthony D ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; MAGNESIUM SULFATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG POTENTIATION; DRUG TOLERANCE; INTRATHECAL DRUG ADMINISTRATION; MAGNESIUM BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

ANALGESIA; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG SYNERGISM; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, SPINAL; MAGNESIUM SULFATE; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0031956271     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199804000-00028     Document Type: Article

References (25)

1. Cotman CW, Iversen LL. Excitatory amino acids in the brain: focus on NMDA receptors. Trends Neurosci 1987;10:263-5.
2. Ascher P, Nowak L. Electrophysiological studies of NMDA receptors. Trends Neurosci 1987;10:284-8.
3. Wong EHF, Kemp JA. Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Annu Rev Pharmacol Toxicol 1991;31:401-25.
4. Xiao WH, Bennett GJ. Magnesium suppresses neuropathic pain responses in rats via a spinal site of action. Brain Res 1994;666: 168-72.
5. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS. NMDA receptor blockade in chronic neuropathic pain: a combination of ketamine and magnesium chloride. Pain 1995;64:283-91.
6. Tramèr MR, Schneider J, René-Andreas M, Rifat K. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996;84:340-7.
7. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991;251:85-7.
8. Marek P, Ben Eliyahu S, Gold M, Liebeskind JS. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 1991;547:77-81.
9. Dunbar S, Yaksh TL. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 1996;84: 1177-88.
10. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989;244:1360-2.
11. Stevens CW, Yaksh TL. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J Pharmacol Exp Ther 1986;238:833-8.
12. B receptors in the rat substantia gelatinosa. J Neurosurg 1993;79:544-9.
13. Yaksh TL, Kohl RL, Rudy TA. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur J Pharmacol 1977;42:275-84.
14. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. 2nd ed. New York: Springer-Verlag, 1987:26-31.
15. Marsala M, Malmberg AB, Yaksh TL. The spinal loop dialysis catheter: characterization of use in the unanesthetized rat. J Neurosci Methods 1995;62:43-53.
16. Wang Y, Wong SL, Sawchuk RJ. Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharmacol Res 1993;10:1411-9.
17. Bahar M, Chanimov M, Grinspun E, et al. Spinal anesthesia induced by intrathecal magnesium sulfate. Anaesthesia 1996;51: 627-33.
18. Ben Eliyahu S, Marek P, Vaccarino AL, et al. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res 1992;575:304-8.
19. Kest B, Marek P, Liebeskind JC. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488 but not morphine antinociception. Brain Res 1992;589:139-42.
20. Yamamoto T, Yaksh TL. Studies on the spinal interaction of morphine and the NMDA antagonist MK801 on the hyperesthesia observed in the rat model of sciatic mononeuropathy. Neurosci Let 1992;135:67-70.
21. Yang CY, Wong CS, Chang JY, Ho ST. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 1996;43:379-83.
22. Manning BH, Mao J, Frenk H, et al. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 1996;67:79-88.
23. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 1987;157:1435-8.
24. Fisher RS, Kaplan PW, Krumholz A, et al. Failure of high-dose intravenous magnesium sulfate to control myoclonic status epilepticus. Clin Neuropharmacol 1988;11:537-44.
25. Ault B, Evans RH, Francis AA, et al. Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations. J Physiol 1980;307: 413-28.